The analysis of Johnson&Johnson

What?

On Saturday, the US Food and Drug Administration approved Johnson&Johnson’s vaccine for emergency use against Covid-19. According to the regulator’s plan, the government will start the distribution of nearly 4 million doses of JNJ’s vaccine across the nation as soon as this week. This is the third vaccine to be supplied to the pharmacies and community health centers of the United States after Pfizer’s and Moderna’s ones. The newly approved vaccine has some unique features, though. Firstly, it requires only one dose. Secondly, it can be stored at refrigerator temperatures for months. The overall effectiveness of Johnson&Johnson’s vaccine varies by region with 72% in the United States, 66% in Latin America, and 57% in South Africa. The numbers seem low in comparison with Moderna’s or Pfizer’s vaccines. However, experts tell that the vaccines are hard to compare, as Johnson&Johnson is a single-shot vaccine and the trial was conducted when there were more infections. At the same time, the company announced the 100% effectiveness against death and hospitalizations caused by Covid-19.

Dr. Anthony Fauci, the chief medical advisor to President Joe Biden, told Americans not to hesitate the vaccine by J&J. According to his words, “It’s not the weaker vaccine, they are all three really good vaccines.”

What does it mean for the stock?

The news has definitely improved risk sentiment in the market. As for the JNJ stock itself, it was trading at 161.64 pre-market, rising by 2.01% from Friday’s close. Last month, the JNJ stock broke the uptrend and fell below the 160 level. Given current optimism, there is a possibility for it to restore its stronger position. The first resistance for the stock lies at 164.4. In case of the cautious risk, the stock will fall to 156.7.

Besides, you can trade stocks in our app FBS Trader!

IMG_20210301_161529.004.jpg

Don't know how to trade stocks? Here are some simple steps.

First of all, be sure you’ve downloaded Metatrader 5 or FBS Trader app. FBS allows you to trade stocks only through this software.
Open the MT5 account in your personal area (an account in FBS Trader).
Start trading!

stocks market

stock

stock trading

Ekaterina Gorbatenko

More by this author

Similar

15.10.2021 12:36 What will move the market on October 18-22?

The bullish movement in the stock market is gaining speed, and Bitcoin ETFs are closer than they might seem. What do we need to know for the next trading week?

22.09.2021 16:37 What to expect from Microsoft event?

On Wednesday, September 22, Microsoft will be holding a product launch. The event starts at 18:00 GTM + 3.

15.09.2021 14:33 Apple event surprised traders

Every year in early autumn Apple holds its event where it presents new iPhones, Apple Watches, and iPads. This year wasn’t an exclusion. But yesterday’s presentation didn’t result in Apple stock growth, and here’s why.